Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PD-1 and PD-L1 Antibody Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 PD-1 inhibitor
1.2.3 PD-L1 inhibitor
1.3 Market by Application
1.3.1 Global PD-1 and PD-L1 Antibody Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Solid Tumors
1.3.3 Blood-related Tumors
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global PD-1 and PD-L1 Antibody Market Perspective (2018-2033)
2.2 PD-1 and PD-L1 Antibody Growth Trends by Region
2.2.1 Global PD-1 and PD-L1 Antibody Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 PD-1 and PD-L1 Antibody Historic Market Size by Region (2018-2023)
2.2.3 PD-1 and PD-L1 Antibody Forecasted Market Size by Region (2024-2033)
2.3 PD-1 and PD-L1 Antibody Market Dynamics
2.3.1 PD-1 and PD-L1 Antibody Industry Trends
2.3.2 PD-1 and PD-L1 Antibody Market Drivers
2.3.3 PD-1 and PD-L1 Antibody Market Challenges
2.3.4 PD-1 and PD-L1 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PD-1 and PD-L1 Antibody Players by Revenue
3.1.1 Global Top PD-1 and PD-L1 Antibody Players by Revenue (2018-2023)
3.1.2 Global PD-1 and PD-L1 Antibody Revenue Market Share by Players (2018-2023)
3.2 Global PD-1 and PD-L1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PD-1 and PD-L1 Antibody Revenue
3.4 Global PD-1 and PD-L1 Antibody Market Concentration Ratio
3.4.1 Global PD-1 and PD-L1 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PD-1 and PD-L1 Antibody Revenue in 2022
3.5 PD-1 and PD-L1 Antibody Key Players Head office and Area Served
3.6 Key Players PD-1 and PD-L1 Antibody Product Solution and Service
3.7 Date of Enter into PD-1 and PD-L1 Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PD-1 and PD-L1 Antibody Breakdown Data by Type
4.1 Global PD-1 and PD-L1 Antibody Historic Market Size by Type (2018-2023)
4.2 Global PD-1 and PD-L1 Antibody Forecasted Market Size by Type (2024-2033)
5 PD-1 and PD-L1 Antibody Breakdown Data by Application
5.1 Global PD-1 and PD-L1 Antibody Historic Market Size by Application (2018-2023)
5.2 Global PD-1 and PD-L1 Antibody Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America PD-1 and PD-L1 Antibody Market Size (2018-2033)
6.2 North America PD-1 and PD-L1 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America PD-1 and PD-L1 Antibody Market Size by Country (2018-2023)
6.4 North America PD-1 and PD-L1 Antibody Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PD-1 and PD-L1 Antibody Market Size (2018-2033)
7.2 Europe PD-1 and PD-L1 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe PD-1 and PD-L1 Antibody Market Size by Country (2018-2023)
7.4 Europe PD-1 and PD-L1 Antibody Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PD-1 and PD-L1 Antibody Market Size (2018-2033)
8.2 Asia-Pacific PD-1 and PD-L1 Antibody Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region (2018-2023)
8.4 Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PD-1 and PD-L1 Antibody Market Size (2018-2033)
9.2 Latin America PD-1 and PD-L1 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America PD-1 and PD-L1 Antibody Market Size by Country (2018-2023)
9.4 Latin America PD-1 and PD-L1 Antibody Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PD-1 and PD-L1 Antibody Market Size (2018-2033)
10.2 Middle East & Africa PD-1 and PD-L1 Antibody Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country (2018-2023)
10.4 Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca PD-1 and PD-L1 Antibody Introduction
11.1.4 AstraZeneca Revenue in PD-1 and PD-L1 Antibody Business (2018-2023)
11.1.5 AstraZeneca Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Detail
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Antibody Introduction
11.2.4 Bristol-Myers Squibb Revenue in PD-1 and PD-L1 Antibody Business (2018-2023)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Detail
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche PD-1 and PD-L1 Antibody Introduction
11.3.4 F. Hoffmann-La Roche Revenue in PD-1 and PD-L1 Antibody Business (2018-2023)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck PD-1 and PD-L1 Antibody Introduction
11.4.4 Merck Revenue in PD-1 and PD-L1 Antibody Business (2018-2023)
11.4.5 Merck Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer PD-1 and PD-L1 Antibody Introduction
11.5.4 Pfizer Revenue in PD-1 and PD-L1 Antibody Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche PD-1 and PD-L1 Antibody Introduction
11.6.4 Roche Revenue in PD-1 and PD-L1 Antibody Business (2018-2023)
11.6.5 Roche Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis PD-1 and PD-L1 Antibody Introduction
11.7.4 Novartis Revenue in PD-1 and PD-L1 Antibody Business (2018-2023)
11.7.5 Novartis Recent Development
11.8 Jiangsu HengRui Medicine
11.8.1 Jiangsu HengRui Medicine Company Detail
11.8.2 Jiangsu HengRui Medicine Business Overview
11.8.3 Jiangsu HengRui Medicine PD-1 and PD-L1 Antibody Introduction
11.8.4 Jiangsu HengRui Medicine Revenue in PD-1 and PD-L1 Antibody Business (2018-2023)
11.8.5 Jiangsu HengRui Medicine Recent Development
11.9 Innovent
11.9.1 Innovent Company Detail
11.9.2 Innovent Business Overview
11.9.3 Innovent PD-1 and PD-L1 Antibody Introduction
11.9.4 Innovent Revenue in PD-1 and PD-L1 Antibody Business (2018-2023)
11.9.5 Innovent Recent Development
11.10 Eli Lilly
11.10.1 Eli Lilly Company Detail
11.10.2 Eli Lilly Business Overview
11.10.3 Eli Lilly PD-1 and PD-L1 Antibody Introduction
11.10.4 Eli Lilly Revenue in PD-1 and PD-L1 Antibody Business (2018-2023)
11.10.5 Eli Lilly Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Detail
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline PD-1 and PD-L1 Antibody Introduction
11.11.4 GlaxoSmithKline Revenue in PD-1 and PD-L1 Antibody Business (2018-2023)
11.11.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global PD-1 and PD-L1 Antibody Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of PD-1 inhibitor
Table 3. Key Players of PD-L1 inhibitor
Table 4. Global PD-1 and PD-L1 Antibody Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global PD-1 and PD-L1 Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global PD-1 and PD-L1 Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global PD-1 and PD-L1 Antibody Market Share by Region (2018-2023)
Table 8. Global PD-1 and PD-L1 Antibody Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global PD-1 and PD-L1 Antibody Market Share by Region (2024-2033)
Table 10. PD-1 and PD-L1 Antibody Market Trends
Table 11. PD-1 and PD-L1 Antibody Market Drivers
Table 12. PD-1 and PD-L1 Antibody Market Challenges
Table 13. PD-1 and PD-L1 Antibody Market Restraints
Table 14. Global PD-1 and PD-L1 Antibody Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global PD-1 and PD-L1 Antibody Market Share by Players (2018-2023)
Table 16. Global Top PD-1 and PD-L1 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Antibody as of 2022)
Table 17. Ranking of Global Top PD-1 and PD-L1 Antibody Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by PD-1 and PD-L1 Antibody Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players PD-1 and PD-L1 Antibody Product Solution and Service
Table 21. Date of Enter into PD-1 and PD-L1 Antibody Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global PD-1 and PD-L1 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global PD-1 and PD-L1 Antibody Revenue Market Share by Type (2018-2023)
Table 25. Global PD-1 and PD-L1 Antibody Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global PD-1 and PD-L1 Antibody Revenue Market Share by Type (2024-2033)
Table 27. Global PD-1 and PD-L1 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global PD-1 and PD-L1 Antibody Revenue Market Share by Application (2018-2023)
Table 29. Global PD-1 and PD-L1 Antibody Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global PD-1 and PD-L1 Antibody Revenue Market Share by Application (2024-2033)
Table 31. North America PD-1 and PD-L1 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America PD-1 and PD-L1 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America PD-1 and PD-L1 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe PD-1 and PD-L1 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe PD-1 and PD-L1 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe PD-1 and PD-L1 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific PD-1 and PD-L1 Antibody Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific PD-1 and PD-L1 Antibody Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America PD-1 and PD-L1 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America PD-1 and PD-L1 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America PD-1 and PD-L1 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa PD-1 and PD-L1 Antibody Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa PD-1 and PD-L1 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 46. AstraZeneca Company Detail
Table 47. AstraZeneca Business Overview
Table 48. AstraZeneca PD-1 and PD-L1 Antibody Product
Table 49. AstraZeneca Revenue in PD-1 and PD-L1 Antibody Business (2018-2023) & (US$ Million)
Table 50. AstraZeneca Recent Development
Table 51. Bristol-Myers Squibb Company Detail
Table 52. Bristol-Myers Squibb Business Overview
Table 53. Bristol-Myers Squibb PD-1 and PD-L1 Antibody Product
Table 54. Bristol-Myers Squibb Revenue in PD-1 and PD-L1 Antibody Business (2018-2023) & (US$ Million)
Table 55. Bristol-Myers Squibb Recent Development
Table 56. F. Hoffmann-La Roche Company Detail
Table 57. F. Hoffmann-La Roche Business Overview
Table 58. F. Hoffmann-La Roche PD-1 and PD-L1 Antibody Product
Table 59. F. Hoffmann-La Roche Revenue in PD-1 and PD-L1 Antibody Business (2018-2023) & (US$ Million)
Table 60. F. Hoffmann-La Roche Recent Development
Table 61. Merck Company Detail
Table 62. Merck Business Overview
Table 63. Merck PD-1 and PD-L1 Antibody Product
Table 64. Merck Revenue in PD-1 and PD-L1 Antibody Business (2018-2023) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Pfizer Company Detail
Table 67. Pfizer Business Overview
Table 68. Pfizer PD-1 and PD-L1 Antibody Product
Table 69. Pfizer Revenue in PD-1 and PD-L1 Antibody Business (2018-2023) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Roche Company Detail
Table 72. Roche Business Overview
Table 73. Roche PD-1 and PD-L1 Antibody Product
Table 74. Roche Revenue in PD-1 and PD-L1 Antibody Business (2018-2023) & (US$ Million)
Table 75. Roche Recent Development
Table 76. Novartis Company Detail
Table 77. Novartis Business Overview
Table 78. Novartis PD-1 and PD-L1 Antibody Product
Table 79. Novartis Revenue in PD-1 and PD-L1 Antibody Business (2018-2023) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. Jiangsu HengRui Medicine Company Detail
Table 82. Jiangsu HengRui Medicine Business Overview
Table 83. Jiangsu HengRui Medicine PD-1 and PD-L1 Antibody Product
Table 84. Jiangsu HengRui Medicine Revenue in PD-1 and PD-L1 Antibody Business (2018-2023) & (US$ Million)
Table 85. Jiangsu HengRui Medicine Recent Development
Table 86. Innovent Company Detail
Table 87. Innovent Business Overview
Table 88. Innovent PD-1 and PD-L1 Antibody Product
Table 89. Innovent Revenue in PD-1 and PD-L1 Antibody Business (2018-2023) & (US$ Million)
Table 90. Innovent Recent Development
Table 91. Eli Lilly Company Detail
Table 92. Eli Lilly Business Overview
Table 93. Eli Lilly PD-1 and PD-L1 Antibody Product
Table 94. Eli Lilly Revenue in PD-1 and PD-L1 Antibody Business (2018-2023) & (US$ Million)
Table 95. Eli Lilly Recent Development
Table 96. GlaxoSmithKline Company Detail
Table 97. GlaxoSmithKline Business Overview
Table 98. GlaxoSmithKline PD-1 and PD-L1 Antibody Product
Table 99. GlaxoSmithKline Revenue in PD-1 and PD-L1 Antibody Business (2018-2023) & (US$ Million)
Table 100. GlaxoSmithKline Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PD-1 and PD-L1 Antibody Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global PD-1 and PD-L1 Antibody Market Share by Type: 2022 VS 2033
Figure 3. PD-1 inhibitor Features
Figure 4. PD-L1 inhibitor Features
Figure 5. Global PD-1 and PD-L1 Antibody Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global PD-1 and PD-L1 Antibody Market Share by Application: 2022 VS 2033
Figure 7. Solid Tumors Case Studies
Figure 8. Blood-related Tumors Case Studies
Figure 9. PD-1 and PD-L1 Antibody Report Years Considered
Figure 10. Global PD-1 and PD-L1 Antibody Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global PD-1 and PD-L1 Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global PD-1 and PD-L1 Antibody Market Share by Region: 2022 VS 2033
Figure 13. Global PD-1 and PD-L1 Antibody Market Share by Players in 2022
Figure 14. Global Top PD-1 and PD-L1 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Antibody as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by PD-1 and PD-L1 Antibody Revenue in 2022
Figure 16. North America PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America PD-1 and PD-L1 Antibody Market Share by Country (2018-2033)
Figure 18. United States PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe PD-1 and PD-L1 Antibody Market Share by Country (2018-2033)
Figure 22. Germany PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific PD-1 and PD-L1 Antibody Market Share by Region (2018-2033)
Figure 30. China PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America PD-1 and PD-L1 Antibody Market Share by Country (2018-2033)
Figure 38. Mexico PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa PD-1 and PD-L1 Antibody Market Share by Country (2018-2033)
Figure 42. Turkey PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia PD-1 and PD-L1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. AstraZeneca Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2018-2023)
Figure 45. Bristol-Myers Squibb Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2018-2023)
Figure 46. F. Hoffmann-La Roche Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2018-2023)
Figure 47. Merck Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2018-2023)
Figure 48. Pfizer Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2018-2023)
Figure 49. Roche Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2018-2023)
Figure 50. Novartis Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2018-2023)
Figure 51. Jiangsu HengRui Medicine Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2018-2023)
Figure 52. Innovent Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2018-2023)
Figure 53. Eli Lilly Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2018-2023)
Figure 54. GlaxoSmithKline Revenue Growth Rate in PD-1 and PD-L1 Antibody Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed